Hip fractures risks in edoxaban versus warfarin users: A propensity score-matched population-based cohort study with competing risk analyses

Zhou, JD; Lee, SR; Liu, XJ; Satti, DI; Lee, TTL; Chou, OHI; Chang, C; Roever, L; Wong, WT; Wai, AKC; Liu, T; Zhang, QP; Tse, G

Tse, G (通讯作者),Tianjin Med Univ, Tianjin Inst Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Dept Cardiol,Hosp 2, Tianjin, Peoples R China.;Tse, G (通讯作者),Kent & Medway Med Sch, Canterbury, Kent, England.;Zhang, QP (通讯作者),City Univ Hong Kong, Sch Data Sci, Hong Kong, Peoples R China.

BONE, 2022; 156 ():

Abstract

Objective: The three direct oral anticoagulants (DOAC), rivaroxaban, apixaban and dabigatran have been associated with lower risks of fractures compar......

Full Text Link